Literature DB >> 3258871

Immunocytochemical study of the cellular immune response in meningiomas.

M L Rossi1, F Cruz Sanchez, J T Hughes, M M Esiri, H B Coakham.   

Abstract

Twenty four meningiomas (17 benign and seven "atypical" were reacted with a panel of monoclonal antibodies to macrophages, lymphocytes, and HLA DR antigens. All the tumours contained macrophages but these cells were more numerous in the atypical meningiomas. Lymphocytes, almost exclusively of the CD8 subtype, were also present in 70% of benign meningiomas and in all atypical meningiomas and were more abundant in the latter. B lymphocytes were present in minimal numbers in three atypical meningiomas and in one benign meningioma. CD4 positive T lymphocytes were present in small numbers in one benign meningioma and in moderate numbers in one atypical meningioma. HLA DR antigen expression on tumour cells was present in about 60% of both tumour groups. The numbers of macrophages and T and CD8 lymphocytes in meningiomas seem to be related to atypical histological features, and the presence of these cells raises questions about host immune response and the relation of this to prognosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258871      PMCID: PMC1141431          DOI: 10.1136/jcp.41.3.314

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.

Authors:  N L Levy
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients.

Authors:  R E Woosley; M S Mahaley; J L Mahaley; G M Miller; W H Brooks
Journal:  J Neurosurg       Date:  1977-12       Impact factor: 5.115

3.  Lymphocytic infiltration in gliomas: evidence of possible host resistance.

Authors:  A Ridley; J B Cavanagh
Journal:  Brain       Date:  1971       Impact factor: 13.501

4.  Immunohistological study of mononuclear cell infiltrate in malignant gliomas.

Authors:  M L Rossi; J T Hughes; M M Esiri; H B Coakham; D B Brownell
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.

Authors:  M S Mahaley; W H Brooks; T L Roszman; D D Bigner; L Dudka; S Richardson
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

6.  Immunofluorescence study of lymphocytic infiltration in gliomas. Identification of T-lymphocytes.

Authors:  D Stavrou; A P Anzil; W Weidenbach; H Rodt
Journal:  J Neurol Sci       Date:  1977-08       Impact factor: 3.181

7.  Perivascular lymphocytic cuffing in astrocytomas.

Authors:  J Takeuchi; R O Barnard
Journal:  Acta Neuropathol       Date:  1976       Impact factor: 17.088

Review 8.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

9.  [Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].

Authors:  D Schiffer; G Croveri; C Pautasso
Journal:  Tumori       Date:  1974 May-Jun

10.  Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Authors:  W H Brooks; M G Netsky; D E Normansell; D A Horwitz
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  27 in total

1.  NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.

Authors:  John W Rutland; Corey M Gill; Joshua Loewenstern; Hanane Arib; Margaret Pain; Melissa Umphlett; Yayoi Kinoshita; Russell B McBride; Joshua Bederson; Michael Donovan; Robert Sebra; Raj K Shrivastava; Mary Fowkes
Journal:  Cancer Immunol Immunother       Date:  2020-07-13       Impact factor: 6.968

2.  Value of AgNOR method in predicting recurrence of meningioma.

Authors:  A P Boon; H Sharif
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

Review 3.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

4.  Probing the human natural autoantibody repertoire using an immunoscreening approach.

Authors:  N Comtesse; D Heckel; E Maldener; B Glass; E Meese
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

5.  The histopathological spectrum of human meningiomas.

Authors:  Thomas Backer-Grøndahl; Bjørnar H Moen; Sverre H Torp
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

Review 6.  Meningioma Tumor Microenvironment.

Authors:  Sajad Sahab-Negah; Ali Gorji
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  An immunohistochemical study on HLA-DR expression in human meningiomas.

Authors:  N Ohara; K Hayashi; K Miyake; H J Jeon; K Takahashi; T Akagi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Growth factor (M-CSF) and antigenic properties of macrophages in meningioma.

Authors:  B Giometto; F Bozza; P Gallo; S Pagni; V Argentiero; S Ferla; S Mingrino; B Tavolato
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

9.  A sequential cell kinetic study of meningioma cells in primary explant culture using bromodeoxyuridine.

Authors:  K Kharbanda; A K Karak; C Sarkar; A K Dinda; M Mathur; S Roy
Journal:  J Neurooncol       Date:  1993-05       Impact factor: 4.130

10.  Mononuclear cell infiltrate and HLA-DR expression in low grade astrocytomas. An immunohistological study of 23 cases.

Authors:  M L Rossi; F Cruz-Sanchez; J T Hughes; M M Esiri; H B Coakham; T H Moss
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.